BOLT vs TWLO · rev $7.7M vs P/E 1087, rev $4.46B
Bolt Biotherapeutics (BOLT) versus Twilio Inc (TWLO) — a side-by-side from cached financials, not a winner call.
Bolt Biotherapeutics (BOLT) is a biotechnology company listed on US.
Twilio Inc (TWLO) is a software - infrastructure company listed on US.
Latest reported BOLT revenue for 2024-12-31 was $7.7M. Net income was -$63.1M. Revenue was down 2.4% from 2023-12-31 to 2024-12-31. BOLT currently screens at market cap $11.3M.
Latest reported TWLO revenue for 2024-12-31 was $4.46B. Net income was -$109.4M. Revenue was up 7.3% from 2023-12-31 to 2024-12-31. TWLO currently screens at market cap $16.67B and trailing P/E 1086.7.
BOLT currently screens at market cap $11.3M. TWLO currently screens at market cap $16.67B and trailing P/E 1086.7.
Not investment advice. Open the BOLT and TWLO stock pages for the full models.
Not investment advice.